• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

机器学习预测经静脉导线拔除术患者的主要不良事件:使用 ESC EHRA EORP 欧洲导线拔除术 CONtrolled ELECTRa 注册研究。

Machine learning-derived major adverse event prediction of patients undergoing transvenous lead extraction: Using the ESC EHRA EORP European lead extraction ConTRolled ELECTRa registry.

机构信息

School of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital, London, United Kingdom; Cardiology Department, Guy's and St Thomas' Hospital, London, United Kingdom.

School of Biomedical Engineering and Imaging Sciences, King's College London, St Thomas' Hospital, London, United Kingdom.

出版信息

Heart Rhythm. 2022 Jun;19(6):885-893. doi: 10.1016/j.hrthm.2021.12.036. Epub 2022 Apr 28.

DOI:10.1016/j.hrthm.2021.12.036
PMID:35490083
Abstract

BACKGROUND

Transvenous lead extraction (TLE) remains a high-risk procedure.

OBJECTIVE

The purpose of this study was to develop a machine learning (ML)-based risk stratification system to predict the risk of major adverse events (MAEs) after TLE. A MAE was defined as procedure-related major complication and procedure-related death.

METHODS

We designed and evaluated an ML-based risk stratification system trained using the European Lead Extraction ConTRolled (ELECTRa) registry to predict the risk of MAEs in 3555 patients undergoing TLE and tested this on an independent registry of 1171 patients. ML models were developed, including a self-normalizing neural network (SNN), stepwise logistic regression model ("stepwise model"), support vector machines, and random forest model. These were compared with the ELECTRa Registry Outcome Score (EROS) for MAEs.

RESULTS

There were 53 MAEs (1.7%) in the training cohort and 24 (2.4%) in the test cohort. Thirty-two clinically important features were used to train the models. ML techniques were similar to EROS by balanced accuracy (stepwise model: 0.74 vs EROS: 0.70) and superior by area under the curve (support vector machines: 0.764 vs EROS: 0.677). The SNN provided a finite risk for MAE and accurately identified MAE in 14 of 169 "high (>80%) risk" patients (8.3%) and no MAEs in all 198 "low (<20%) risk" patients (100%).

CONCLUSION

ML models incrementally improved risk prediction for identifying those at risk of MAEs. The SNN has the additional advantage of providing a personalized finite risk assessment for patients. This may aid patient decision making and allow better preoperative risk assessment and resource allocation.

摘要

背景

经静脉导线拔除术(TLE)仍然是一项高风险的操作。

目的

本研究旨在开发一种基于机器学习(ML)的风险分层系统,以预测 TLE 后发生主要不良事件(MAEs)的风险。MAE 定义为与操作相关的严重并发症和与操作相关的死亡。

方法

我们设计并评估了一种基于 ML 的风险分层系统,该系统使用欧洲经静脉导线拔除术控制(ELECTRa)注册中心的数据进行训练,以预测 3555 例 TLE 患者发生 MAEs 的风险,并在 1171 例患者的独立注册中心进行了测试。开发了 ML 模型,包括自归一化神经网络(SNN)、逐步逻辑回归模型(“逐步模型”)、支持向量机和随机森林模型。将这些模型与 MAEs 的 ELECTRa 注册中心结果评分(EROS)进行比较。

结果

在训练队列中发生 53 例 MAEs(1.7%),在测试队列中发生 24 例(2.4%)。使用 32 个有临床意义的特征来训练模型。ML 技术在平衡准确性方面与 EROS 相似(逐步模型:0.74 vs EROS:0.70),在曲线下面积方面优于 EROS(支持向量机:0.764 vs EROS:0.677)。SNN 提供了 MAE 的有限风险,并在 169 例“高(>80%)风险”患者中的 14 例(8.3%)中准确识别 MAE,在所有 198 例“低(<20%)风险”患者中均未发生 MAE(100%)。

结论

ML 模型可逐步提高识别 MAE 风险的能力。SNN 具有提供个性化有限风险评估的额外优势。这可能有助于患者决策,并允许更好地进行术前风险评估和资源分配。

相似文献

1
Machine learning-derived major adverse event prediction of patients undergoing transvenous lead extraction: Using the ESC EHRA EORP European lead extraction ConTRolled ELECTRa registry.机器学习预测经静脉导线拔除术患者的主要不良事件:使用 ESC EHRA EORP 欧洲导线拔除术 CONtrolled ELECTRa 注册研究。
Heart Rhythm. 2022 Jun;19(6):885-893. doi: 10.1016/j.hrthm.2021.12.036. Epub 2022 Apr 28.
2
Risk stratification of patients undergoing transvenous lead extraction with the ELECTRa Registry Outcome Score (EROS): an ESC EHRA EORP European lead extraction ConTRolled ELECTRa registry analysis.ELECTRa 注册结局评分(EROS)评估行经静脉导线拔除术患者的风险分层:ESC-EHRA-EORP 欧洲导线拔除对照 ELECTRa 注册分析。
Europace. 2021 Sep 8;23(9):1462-1471. doi: 10.1093/europace/euab037.
3
The effect of centre volume and procedure location on major complications and mortality from transvenous lead extraction: an ESC EHRA EORP European Lead Extraction ConTRolled ELECTRa registry subanalysis.中心容积和手术部位对经静脉导线拔除主要并发症及死亡率的影响:一项ESC EHRA EORP欧洲导线拔除对照ELECTRa注册研究的亚分析
Europace. 2020 Nov 1;22(11):1718-1728. doi: 10.1093/europace/euaa131.
4
The European Lead Extraction ConTRolled (ELECTRa) study: a European Heart Rhythm Association (EHRA) Registry of Transvenous Lead Extraction Outcomes.欧洲经皮心脏电生理导线拔除控制(ELECTRa)研究:一项经欧洲心律协会(EHRA)注册的经静脉导线拔除结果研究。
Eur Heart J. 2017 Oct 21;38(40):2995-3005. doi: 10.1093/eurheartj/ehx080.
5
Major cardiac and vascular complications after transvenous lead extraction: acute outcome and predictive factors from the ESC-EHRA ELECTRa (European Lead Extraction ConTRolled) registry.经静脉导线拔除术后的主要心脏和血管并发症:来自 ESC-EHRA ELECTRa(欧洲导线拔除术对照)注册研究的急性结局和预测因素。
Europace. 2019 May 1;21(5):771-780. doi: 10.1093/europace/euy300.
6
Clinical impact of antithrombotic therapy in transvenous lead extraction complications: a sub-analysis from the ESC-EORP EHRA ELECTRa (European Lead Extraction ConTRolled) Registry.经静脉导线拔除并发症中抗栓治疗的临床影响:ESC-EORP EHRA ELECTRa(欧洲导线拔除对照)注册研究的亚分析。
Europace. 2019 Jul 1;21(7):1096-1105. doi: 10.1093/europace/euz062.
7
Procedural outcomes associated with transvenous lead extraction in patients with abandoned leads: an ESC-EHRA ELECTRa (European Lead Extraction ConTRolled) Registry Sub-Analysis.与废弃导线经静脉导线拔除术相关的操作结果:ESC-EHRA ELECTRa(欧洲导线拔除对照)注册研究的亚组分析。
Europace. 2019 Apr 1;21(4):645-654. doi: 10.1093/europace/euy307.
8
Enhancing transvenous lead extraction risk prediction: Integrating imaging biomarkers into machine learning models.提高经静脉导线拔除风险预测:将影像生物标志物整合到机器学习模型中。
Heart Rhythm. 2024 Jun;21(6):919-928. doi: 10.1016/j.hrthm.2024.02.015. Epub 2024 Feb 12.
9
Transvenous lead extraction procedures in women based on ESC-EHRA EORP European Lead Extraction ConTRolled ELECTRa registry: is female sex a predictor of complications?基于 ESC-EHRA EORP 欧洲经皮心脏介入器械注册研究中心的经静脉心脏导线拔除术在女性中的应用:女性性别是并发症的预测因素吗?
Europace. 2019 Dec 1;21(12):1890-1899. doi: 10.1093/europace/euz277.
10
The effect of centre volume and procedure location on major complications and mortality from transvenous lead extraction: an ESC EHRA EORP European Lead Extraction ConTRolled ELECTRa registry subanalysis.中心容积和手术部位对经静脉导线拔除主要并发症和死亡率的影响:一项ESC EHRA EORP欧洲导线拔除对照ELECTRa注册研究的亚分析
Europace. 2021 Jul 18;23(7):1149. doi: 10.1093/europace/euab038.

引用本文的文献

1
To Extract or not To Extract? Navigating Lead Failure in Cardiac Devices.提取还是不提取?应对心脏设备中的导线故障
Curr Cardiol Rep. 2025 Sep 17;27(1):133. doi: 10.1007/s11886-025-02282-z.
2
Management of patients with transvalvular right ventricular leads undergoing transcatheter tricuspid valve interventions: a scientific statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions of the ESC endorsed by the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society and the Canadian Heart Rhythm Society.经导管三尖瓣介入治疗中经瓣右心室导线患者的管理:欧洲心脏节律协会和欧洲心脏病学会经皮心血管介入协会的科学声明,得到心律学会、亚太心脏节律学会和加拿大心脏节律学会认可
Europace. 2025 May 7;27(5). doi: 10.1093/europace/euaf061.